MARY MITCHELL: Open Payments
NPI 1215041058 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 46 payments from 14 companies in 2025. Trend: 2023 $453 · 2024 $616 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $213 |
| GlaxoSmithKline, LLC. | 8 | $135 |
| Novo Nordisk Inc | 4 | $73 |
| Stryker Corporation | 1 | $44 |
| Lilly USA, LLC | 3 | $44 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Amgen Inc. | 2 | $30 |
| Ardelyx, Inc. | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 4 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
Products named: UBRELVY, TRELEGY ELLIPTA, SHINGRIX, Ozempic, CLOTTRIEVER BOLD CATHETER, MOUNJARO, Auvelity, CREON.
Industry payments across SC — which companies pay providers there.
